PedAM
Pediatric Disease Annotations & Medicines
| Disease | invasive aspergillosis |
| Phenotype | C0376545|hematologic malignancies |
| Sentences | 6 |
| PubMedID- 23226235 | Itraconazole is commonly used for the treatment of chronic and allergic conditions [2] and posaconazole is effective in preventing invasive aspergillosis in patients with certain hematologic malignancies [7], [8]. |
| PubMedID- 21281234 | Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies. |
| PubMedID- 22712456 | Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. |
| PubMedID- 25018923 | Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin b alone or in combination with caspofungin. |
| PubMedID- 20502511 | Amphotericin b has been the most studied aerosolized antifungal agent for prophylaxis against invasive aspergillosis in patients with hematologic malignancies and lung transplantation. |
| PubMedID- 21791468 | invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. |
Page: 1